Related Experiment Video
Updated: Jun 12, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Risk of Developing Pediatric Uveitis Among Patients With Early-Onset Atopic Dermatitis
Yung-Yu Chu1, Cheng-Hao Sung1, Yu-Shiuan Lin1
1Department of Ophthalmology, Chi Mei Medical Center, Tainan, Taiwan.
Insights
Children with early-onset atopic dermatitis (AD) have a nearly twofold increased risk of developing pediatric uveitis. This risk persists regardless of autoimmune conditions or dupilumab use, highlighting the need for ophthalmologic monitoring in these young patients.
Area of Science:
- Ophthalmology and Dermatology
- Pediatric Health
- Epidemiology
Background:
- The association between atopic dermatitis (AD) and pediatric uveitis is not well-established.
- Large-scale studies are needed to understand the relationship between early-onset AD and the risk of uveitis in children.
- Identifying risk factors for pediatric uveitis is crucial for early detection and management.
Purpose of the Study:
- To evaluate the risk of pediatric uveitis in children with early-onset atopic dermatitis (AD) compared to a control group.
- To assess the influence of autoimmune conditions and dupilumab use on this risk.
- To investigate the association between disease severity in AD and the risk of developing uveitis.
Main Methods:
- A retrospective cohort study utilizing aggregated electronic health records from the TriNetX network.
- Inclusion of children with early-onset AD and matched controls without AD, excluding those with prior uveitis.
- Propensity score matching was used to balance baseline characteristics; Cox proportional hazards models assessed the risk of pediatric uveitis.
Main Results:
- The study identified 114,889 patients with AD and a matched control group.
- Children with early-onset AD showed a significantly higher risk of developing pediatric uveitis (HR, 1.92).
- Increased risk was observed independently of dupilumab use (HR, 1.77) or autoimmune conditions (HR, 1.52), with severe AD patients exhibiting the highest risk (HR, 3.64).
Conclusions:
- Early-onset atopic dermatitis is associated with an elevated risk of pediatric uveitis.
- This risk is independent of autoimmune comorbidities or specific treatments like dupilumab.
- Ophthalmologic monitoring should be considered for children with early-onset AD to facilitate early detection and management of uveitis.
Importance:
The relationship between atopic dermatitis (AD) and pediatric uveitis may be underexplored, warranting large-scale, multicenter studies.
Objective:
To evaluate the risk of pediatric uveitis among children with early-onset AD compared with a matched control population.
Design, Setting, And Participants:
This cohort study used aggregated electronic health records of US patients with early-onset AD and matched controls from January 1, 2004, through December 14, 2024, sourced from health care organizations in the collaborative research network TriNetX. Patients with early-onset AD and matched controls without AD were included in the analysis; those with uveitis prior to AD diagnosis were excluded. Propensity score matching was applied to balance baseline characteristics. The analyses were conducted on December 14, 2024.
Exposure:
International Classification of Diseases, 10th Revision (ICD-10) diagnosis code for AD.
Main Outcomes And Measures:
The primary outcome was the hazard ratio (HR) for developing pediatric uveitis in the AD cohort compared with the matched controls. Cox proportional hazards models were applied to assess the risk.
Results:
A total of 114 889 patients were identified in the AD cohort (mean [SD] follow-up, 6.0 [3.3] years; mean [SD] age, 0.5 [0.7] years; 64 817 male [56.4%]) and the control cohort (mean [SD] follow-up, 6.6 [3.7] years; mean [SD] age, 0.6 [0.8] years; 65 377 male [56.9%]) after matching. The AD cohort demonstrated a higher risk of developing pediatric uveitis compared with controls (94 [0.08%] vs 58 [0.05%]; HR, 1.92 [95% CI, 1.38-2.66]). Sensitivity analyses among patients without dupilumab use (89 of 113 284 [0.08%] vs 59 of 113 284 [0.05%]; HR, 1.77 [95% CI, 1.27-2.46]) and those without autoimmune conditions (80 of 114 425 [0.07%] vs 61 of 114 425 [0.05%]; HR, 1.52 [95% CI, 1.09-2.12]) similarly indicated an increased risk in the AD cohort. Additionally, patients with severe AD had a higher risk of developing pediatric uveitis compared with those with nonsevere AD (12 of 3004 [0.40%] vs 97 of 126 482 [0.08%]; HR, 3.64 [95% CI, 2.00-6.66]).
Conclusions And Relevance:
This cohort study of children with early-onset AD found an elevated risk of pediatric uveitis compared with matched controls, independent of autoimmune conditions or dupilumab use. These findings support the potential need to consider ophthalmologic monitoring in children with early-onset AD to try to detect and subsequently manage uveitis if it develops.
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

